CA2366059A1 - Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer - Google Patents
Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer Download PDFInfo
- Publication number
- CA2366059A1 CA2366059A1 CA002366059A CA2366059A CA2366059A1 CA 2366059 A1 CA2366059 A1 CA 2366059A1 CA 002366059 A CA002366059 A CA 002366059A CA 2366059 A CA2366059 A CA 2366059A CA 2366059 A1 CA2366059 A1 CA 2366059A1
- Authority
- CA
- Canada
- Prior art keywords
- mage
- glu
- seq
- leu
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26097899A | 1999-03-02 | 1999-03-02 | |
US09/260,978 | 1999-03-02 | ||
PCT/US2000/005346 WO2000052163A1 (en) | 1999-03-02 | 2000-03-01 | Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2366059A1 true CA2366059A1 (en) | 2000-09-08 |
Family
ID=22991462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002366059A Abandoned CA2366059A1 (en) | 1999-03-02 | 2000-03-01 | Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1194542A1 (ko) |
JP (1) | JP2003512814A (ko) |
KR (1) | KR20020011967A (ko) |
AU (1) | AU3389500A (ko) |
CA (1) | CA2366059A1 (ko) |
NZ (1) | NZ513739A (ko) |
WO (1) | WO2000052163A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007053956A1 (en) | 2005-11-14 | 2007-05-18 | Universite Laval | Cancer antigen mage-a9 and uses thereof |
WO2019007974A1 (en) | 2017-07-07 | 2019-01-10 | Immatics Biotechnologies Gmbh | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS |
CR20210168A (es) | 2017-07-07 | 2021-06-10 | Immatics Biotechnologies Gmbh | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de pulmón, incluyendo el nsclc, el sclc y otros cánceres |
FR3087448B1 (fr) | 2018-10-23 | 2023-10-13 | Pdc Line Pharma | Lignee pdc modifiee pour secreter une cytokine |
TW202039535A (zh) | 2018-12-18 | 2020-11-01 | 德商英麥提克生物技術股份有限公司 | B*08限制肽和肽組合物抗癌免疫治療和相關方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342774A (en) * | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
US5612201A (en) * | 1991-05-23 | 1997-03-18 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor |
-
2000
- 2000-03-01 EP EP00912112A patent/EP1194542A1/en not_active Withdrawn
- 2000-03-01 NZ NZ513739A patent/NZ513739A/xx not_active Application Discontinuation
- 2000-03-01 WO PCT/US2000/005346 patent/WO2000052163A1/en not_active Application Discontinuation
- 2000-03-01 AU AU33895/00A patent/AU3389500A/en not_active Abandoned
- 2000-03-01 KR KR1020017011090A patent/KR20020011967A/ko not_active Application Discontinuation
- 2000-03-01 CA CA002366059A patent/CA2366059A1/en not_active Abandoned
- 2000-03-01 JP JP2000602775A patent/JP2003512814A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1194542A1 (en) | 2002-04-10 |
KR20020011967A (ko) | 2002-02-09 |
AU3389500A (en) | 2000-09-21 |
NZ513739A (en) | 2001-09-28 |
JP2003512814A (ja) | 2003-04-08 |
WO2000052163A1 (en) | 2000-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100306464B1 (ko) | Mhc분자hla-c-클론10과복합체를형성하는분리된펩티드및그것의사용 | |
CN1318447C (zh) | 得自亲环蛋白b的肿瘤抗原肽 | |
EP0690675B1 (en) | Nucleic acid coding for a tumor rejection antigen precursor | |
Zarour et al. | The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100 | |
US20120123090A1 (en) | Novel tumor antigen protein sart-3 and tumor antigen peptides thereof | |
US6555652B1 (en) | Tumor antigen peptide derivatives | |
US6605711B1 (en) | NY-ESO-1 peptide derivatives, and uses thereof | |
US6913891B1 (en) | Human myeloid terminal differentiation response gene | |
EP1230261B1 (en) | Ny-eso-1 nonapeptide derivatives, and uses thereof | |
US20030180739A1 (en) | Reagents and methods for identifying gene targets for treating cancer | |
JP2003000270A (ja) | 腫瘍抗原 | |
CA2366059A1 (en) | Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer | |
CA2386029A1 (en) | P-glycoproteins from macaca fascicularis and uses thereof | |
JP4190291B2 (ja) | 癌細胞の増殖を調節するのに有用なポリヌクレオチド | |
US5837476A (en) | Methods for determining disorders by assaying for a non-tyrosinase, tumor rejection antigen precursor | |
CN100393745C (zh) | 一种肿瘤抗原蛋白质和肿瘤抗原肽 | |
CA2353102A1 (en) | Novel tumor antigen protein art-1 and tumor antigen peptide thereof | |
CA2182969A1 (en) | Methods for identifying individuals suffering from a cellular abnormality | |
CA2319668C (en) | Human tsc403 gene and human ing1l gene | |
CA2384981A1 (en) | P-glycoproteins and uses thereof | |
CA2165435C (en) | Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof | |
JP2001245675A (ja) | 腫瘍抗原 | |
US7270980B2 (en) | Compounds for immunodiagnosis of prostate cancer and methods for their use | |
CA2300371A1 (en) | 1(3)mbt protein, polynucleotide coding for said protein, antisense polynucleotide thereof, and antibody recognizing said protein | |
AU2313401A (en) | Novel human myeloid terminal differentiation response gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |